Bharat Book Bureau

The medical transcription outsourcing grabbed a lot of media attention in India during 1995 - 97, well before ‘BPO’ became a household term. People were excited about the huge opportunity that India had hit upon. However, the industry witnessed a rough patch around 2000. Today, the USD 195 million strong industry is silently supplying to the USD 12 billion medical transcription industry in the US.

We have classified vendors into three primary groups:

Indian units of large US players - Typically comprise American companies or Medical Transcription Service Organizations (MTSOs) who have successfully set up their transcription centers in India. The large players include CBay, Spheris, Spryance, Acusis and Heartland. These large players account for almost 70 percent of Indian medical transcription offshoring revenues.

Mid-sized players - There are a number of medium sized players (< 500 employees) in India. Most of them work as franchisees or vendors of the larger players and have limited marketing presence in the US.

Smaller players - There are a large number of such small players with <50 employees. These players are subcontractors to the other two groups and suffer from unreliable revenue flows.

It estimates the current employment in the India-based medical transcription vendors is approximately 18,000 and expects this to grow to 52,000 by 2010. According to Arun Jethmalani, CEO, although there will be significant growth in the medical transcription outsourcing space, most of it will be centered around the MTSOs.

The report “The US Medical Transcription Industry: Perspective on Outsourcing and Offshoring” report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Hospitals, healthcare institutions and medical transcription service organizations looking to outsource/offshore
Outsourcing consultants evaluate and compare the offerings of vendors
Medical transcription vendors to assess their competitive environment
American medical transcription companies looking for Indian partners
Venture Capital companies looking for investment opportunities
Researchers looking for detailed information on medical transcription outsourcing
The report is based on secondary data as well as extensive interviews with key people at various medical transcription outsourcing companies in India.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=15095
_______________________________________________________________ 

The Indian offshore insurance services (BPO) industry is estimated to be worth $690 million in 2006, and is expected to grow at a CAGR of 30% a year up to FY2010, driven by the need to reduce costs, differentiate products in an increasingly competitive environment, and ensure regulatory compliance.

The research also expects insurance outsourcing from UK and Europe based insurance carriers to grow faster than US based insurance carriers in the next two to three years. This business will increasingly seek new, innovative business arrangements, which are hybrids between captive and third party models.

The offshore vendor landscape is made up of :

Captives of large insurance carriers, mainly based in the US and Europe, such as Aviva, AXA, Prudential, Allianz, Principal, etc.

Indian offshore third party BPO vendors which include,  

Large third party BPO vendors like Genpact, WNS, EXL Service, etc 
BPO offshoots of IT majors such as TCS, Wipro, Infosys, etc
Mid-tier vendors - mostly large BPO vendors with a relatively small insurance presence - such as IBM Daksh, Patni BPO, HCL BPO, etc
Smaller, undifferentiated vendors

In the future, we will see a rising trend towards outsourcing of higher-end processes such as underwriting, actuaries and analytics to the larger third party BPO vendors, who are fast gaining capabilities in these areas. “By FY2010″, says Arun Jethmalani, CEO,”a large number of Indian vendors will have evolved into mature, end-to-end service providers, competing with multinational outsourcing companies”. Players like Genpact, WNS and EXL Services, as well as BPO offshoots of IT companies like IBM, TCS, Infosys (Progeon) and Wipro will emerge as formidable global players in the next few years.

Arpita Bedekar, analyst at report expects “greater offshoring of high-end, higher-value services like analytics, actuaries and underwriting to push industry average billing rates upwards by more than 25 percent in the next two to three years”.

The report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Insurance companies looking to outsource/offshore
Outsourcing consultants to evaluate and compare the offerings of vendors
Insurance services vendors to assess their competitive environment
Venture Capital companies looking for investment opportunities
Researchers looking for detailed information on financial services offshoring  
This study is based on secondary data as well as extensive interviews with key people at various BPOs (captive as well as third-party) in India.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=25417
_______________________________________________________________

In the future, we will see a rising trend towards outsourcing of higher-end processes such as underwriting, actuaries and analytics to the larger third party BPO vendors, who are fast gaining capabilities in these areas. “By FY2010″, says Arun Jethmalani, CEO,”a large number of Indian vendors will have evolved into mature, end-to-end service providers, competing with multinational outsourcing companies”. Players like Genpact, WNS and EXL Services, as well as BPO offshoots of IT companies like IBM, TCS, Infosys (Progeon) and Wipro will emerge as formidable global players in the next few years.

Arpita Bedekar, analyst at report expects “greater offshoring of high-end, higher-value services like analytics, actuaries and underwriting to push industry average billing rates upwards by more than 25 percent in the next two to three years”.

The report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Insurance companies looking to outsource/offshore
Outsourcing consultants to evaluate and compare the offerings of vendors
Insurance services vendors to assess their competitive environment
Venture Capital companies looking for investment opportunities
Researchers looking for detailed information on financial services offshoring  

This study is based on secondary data as well as extensive interviews with key people at various BPOs (captive as well as third-party) in India.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=25418
_______________________________________________________________

The outsourcing industry is evolving rapidly; as new players, offshore destinations and a bewildering array of new services emerge. This is making it extremely difficult for senior executives at buyer organizations, outsourcing vendors, consultants and investors to stay abreast of the latest happenings in the sector.

The Outsourcing DealTracker is designed to provide comprehensive and up-to-date information on outsourcing to ensure that readers can stay abreast. The newsletter will consist of two parts:

● Mergers and acquisitions activity and venture capital and private equity funding
● Contracts

A comprehensive monthly resource tracking mergers and acquisition activity, venture capital and private equity funding, and contracts in the business process outsourcing and knowledge services outsourcing space. [Scope does not cover deals / contracts in the information technology industry].

The annual subscription, priced at $600, includes:
- twelve issues of the DealTracker which will be emailed as pdf attachment on the 7th of every month,
- 4 quarterly round-ups which will be emailed as pdf attachment on the 7th of January, April, July and October, and
- one annual round-up which will be emailed on the 7th of January.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=50011
_______________________________________________________________

India’s total contract research revenues amount to just USD 75 million, but is expected to grow at 23.6% CAGR, hitting USD 175 million by end 2010. India has emerged as an attractive destination for outsourcing research services owing to its low cost manufacturing, lower cost of R&D personnel, lower capital and operational costs for quality infrastructure of international standards. “The rapidly evolving skill-set of Indian vendors in basic research and development have narrowed the skill-gap required for NCE research. This trend is one of the key attractors for western companies to outsource value added research services from India”, believes Dr Raj Rajagopal, COO KnowGenix.

According to Arun Jethmalani, CEO, “ Establishing preferred vendor status is one of the critical success factors for Indian firms and would be imperative for long-term repeat business. There is an increasing trend amongst the Indian contract research organizations to move up the value chain by becoming preferred vendors of a few global outsourcers than serving as jack-of-all trades. Preferred vendors often land up with high margin contracts such as researching and/ or developing proprietary technologies for the client”.

Going forward, we expect to see Indian vendors expanding their geographical presence and service-offering portfolio through acquisitions. Partnering strategies like licensing arrangements, collaborative research will be increasingly undertaken. According to Suchita Chaudhari, Senior Analyst “Increased involvement of the outsourcing partner is imperative for success in the drug discovery, development and commercialization. This requires new thinking and new processes with an innovative partner”.

Also, companies are moving up the pharmaceutical value chain and developing capabilities in biologics to complement existing chemistry strengths. “Biodrugs are safer and more target specific than conventional drugs. Innovator companies suffering from low R&D productivity are increasingly looking at biopharma to generate leads for NCE research. Hence, we believe that Indian vendors with strengths in biopharma will see success”, says Poonam Bhana, Analyst.

The report “Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India” provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Pharma companies looking to outsource/offshore
Global pharmaceutical companies to gain understanding of the Indian vendor space
Outsourcing consultants to evaluate and compare the offerings of vendors
Potential vendors to assess opportunities
Contract research vendors to assess their competitive environment
Venture capital companies looking for investment opportunities
Researchers looking for detailed information on Contract Research Offshoring

This study is based on secondary data as well as extensive interviews with key people at various contract research organizations (captive as well as third-party) in India.

Soaring drug discovery development times, prolonged regulation-mandated testing, complex review processes, rapidly escalating R&D expenditures and competition are compelling pharmaceutical companies to outsource various services to inexpensive but highly skilled destinations in Asia. This report, based on a study conducted by KnowGenix, examines the contract research outsourcing market in India for the pharmaceutical and biotechnology space.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=50014
_______________________________________________________________

Research companies around the world now feel the need for enormous computing and data management competencies to sequence and categorize data generated by drug-discovery labs. To facilitate the storage, management, retrieval, and analysis of this large-scale data, the application of IT to the life sciences sector - bioinformatics, assumes increasingly higher significance. The use of bioinformatics tools lowers costs, improves efficiency and reduces development-to-launch timelines. The drive to further reduce R&D costs by off-shoring to low cost destinations is fuelling the outsourcing of bioinformatics services from India. This report examines the bioinformatics services outsourcing market in India for the life sciences space.

According to Arun Jethmalani, CEO “Outsourcing to India, compared to other developed countries, offers about 30-40% costs savings in overall drug discovery research, and close to 60% cost savings when outsourcing core bioinformatics services. This is owing to the lower wage costs for skilled manpower, and lower infrastructure costs.”

It estimates that India’s bioinformatics services outsourcing revenues are about USD 32 million, and are expected to grow at a CAGR of 25% touching USD 62 million by 2010. India has emerged as an attractive destination for outsourcing bioinformatics services owing to availability of low cost English-speaking manpower, lower capital and operational costs, and its established success as an IT and pharma outsourcing hub. “Vendors, that lack international visibility for their products, are rapidly building service capabilities to capitalize on the India advantage. Pure play companies offer specialized services, IT companies offer services across the life sciences vertical while domestic life sciences companies are offering a complete research solution that includes bioinformatics services”, says Dr Raj Rajagopal, CCO KnowGenix.

The Indian vendor landscape for bioinformatics services outsourcing is made up of:

Pure bioinformatics companies like Strand Life Sciences, Molecular Connections, VLife Sciences Technologies
Domestic IT companies like Infosys, HCL Technologies, TCS
Domestic companies with focus on CRAMS like Jubilant Biosys, Avesthagen, GVK Biosciences
Multinational IT companies like Mphasis, IBM India
Multinational Pure bioinformatics companies like Cytogenomics, LabVantage
Going forward, we expect vendors to explore alliances or acquisitions to broaden their product/service portfolio, customer base, and geographical reach. Currently, vendors are actively seeking alliances that complement their core competencies and allow them to use emerging technologies in a mutually beneficial and cost competitive manner. Partnering strategies like licensing arrangements, marketing arrangements, and collaborative product development and research partnerships will be increasingly undertaken. According to Suchita Chaudhari “We believe companies offering an integrated services portfolio will enjoy an upper hand, compelling pure play vendors offering only discovery informatics to expand into clinical trials informatics, and / or life sciences research to remain competitive.”

A critical success factor for India as a rising destination for outsourcing bioinformatics services is the availability of quality manpower. “India is facing a shortage of experienced bioinformatics professionals, which is resulting in higher attrition and rising wage levels. These in turn could reduce the cost competitiveness of India over her other counterparts in China, Brazil, Ireland, etc. Government and private initiatives to boost industry-academia interaction, and corporate training initiatives are a step in the right direction,” believes Poonam Bhana, Analyst.
The report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Research companies looking to outsource/off-shore bioinformatics services
Global biotechnology and pharmaceutical companies to gain understanding of the Indian bioinformatics vendor space
Outsourcing consultants to evaluate and compare offerings of Indian bioinformatics vendors
Potential vendors to assess opportunities in India
Bioinformatics vendors to assess the competitive environment in India
Venture capital companies looking for investment opportunities
Researchers looking for detailed information on Bioinformatics services off-shoring to India

This study, is based on extensive interviews with key bioinformatics vendors in India, supplemented with knowledge from secondary sources

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=70033
_______________________________________________________________

Research companies around the world now feel the need for enormous computing and data management competencies to sequence and categorize data generated by drug-discovery labs. To facilitate the storage, management, retrieval, and analysis of this large-scale data, the application of IT to the life sciences sector - bioinformatics, assumes increasingly higher significance. The use of bioinformatics tools lowers costs, improves efficiency and reduces development-to-launch timelines. The drive to further reduce R&D costs by off-shoring to low cost destinations is fuelling the outsourcing of bioinformatics services from India. This report, based on a study conducted examines the bioinformatics services outsourcing market in India for the life sciences space.

According to Arun Jethmalani, CEO, “Outsourcing to India, compared to other developed countries, offers about 30-40% costs savings in overall drug discovery research, and close to 60% cost savings when outsourcing core bioinformatics services. This is owing to the lower wage costs for skilled manpower, and lower infrastructure costs.”

It estimates that India’s bioinformatics services outsourcing revenues are about USD 32 million, and are expected to grow at a CAGR of 25% touching USD 62 million by 2010. India has emerged as an attractive destination for outsourcing bioinformatics services owing to availability of low cost English-speaking manpower, lower capital and operational costs, and its established success as an IT and pharma outsourcing hub. “Vendors, that lack international visibility for their products, are rapidly building service capabilities to capitalize on the India advantage. Pure play companies offer specialized services, IT companies offer services across the life sciences vertical while domestic life sciences companies are offering a complete research solution that includes bioinformatics services”, says Dr Raj Rajagopal, CCO KnowGenix.

The Indian vendor landscape for bioinformatics services outsourcing is made up of:

Pure bioinformatics companies like Strand Life Sciences, Molecular Connections, VLife Sciences Technologies
Domestic IT companies like Infosys, HCL Technologies, TCS
Domestic companies with focus on CRAMS like Jubilant Biosys, Avesthagen, GVK Biosciences
Multinational IT companies like Mphasis, IBM India
Multinational Pure bioinformatics companies like Cytogenomics, LabVantage
Going forward, we expect vendors to explore alliances or acquisitions to broaden their product/service portfolio, customer base, and geographical reach. Currently, vendors are actively seeking alliances that complement their core competencies and allow them to use emerging technologies in a mutually beneficial and cost competitive manner. Partnering strategies like licensing arrangements, marketing arrangements, and collaborative product development and research partnerships will be increasingly undertaken. According to Suchita Chaudhari, Senior Analyst “We believe companies offering an integrated services portfolio will enjoy an upper hand, compelling pure play vendors offering only discovery informatics to expand into clinical trials informatics, and / or life sciences research to remain competitive.”

A critical success factor for India as a rising destination for outsourcing bioinformatics services is the availability of quality manpower. “India is facing a shortage of experienced bioinformatics professionals, which is resulting in higher attrition and rising wage levels. These in turn could reduce the cost competitiveness of India over her other counterparts in China, Brazil, Ireland, etc. Government and private initiatives to boost industry-academia interaction, and corporate training initiatives are a step in the right direction,” believes Poonam Bhana, Analyst.

The report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Research companies looking to outsource/off-shore bioinformatics services
Global biotechnology and pharmaceutical companies to gain understanding of the Indian bioinformatics vendor space
Outsourcing consultants to evaluate and compare offerings of Indian bioinformatics vendors
Potential vendors to assess opportunities in India
Bioinformatics vendors to assess the competitive environment in India
Venture capital companies looking for investment opportunities
Researchers looking for detailed information on Bioinformatics services off-shoring to India

This study, is based on extensive interviews with key bioinformatics vendors in India, supplemented with knowledge from secondary sources.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=70034
_______________________________________________________________

The medical transcription outsourcing grabbed a lot of media attention in India during 1995 - 97, well before ‘BPO’ became a household term. People were excited about the huge opportunity that India had hit upon. However, the industry witnessed a rough patch around 2000. Today, the USD 195 million strong industry is silently supplying to the USD 12 billion medical transcription industry in the US.

We have classified vendors into three primary groups:

Indian units of large US players - Typically comprise American companies or Medical Transcription Service Organizations (MTSOs) who have successfully set up their transcription centers in India. The large players include CBay, Spheris, Spryance, Acusis and Heartland. These large players account for almost 70 percent of Indian medical transcription offshoring revenues.

Mid-sized players - There are a number of medium sized players (< 500 employees) in India. Most of them work as franchisees or vendors of the larger players and have limited marketing presence in the US.

Smaller players - There are a large number of such small players with <50 employees. These players are subcontractors to the other two groups and suffer from unreliable revenue flows.

It estimates the current employment in the India-based medical transcription vendors is approximately 18,000 and expects this to grow to 52,000 by 2010. According to Arun Jethmalani, CEO, although there will be significant growth in the medical transcription outsourcing space, most of it will be centered around the MTSOs.

The report “The US Medical Transcription Industry: Perspective on Outsourcing and Offshoring” report provides an overview of the buyer scenario and an in-depth analysis of the Indian vendor space along with profiles of major industry players. The report is designed to help:

Hospitals, healthcare institutions and medical transcription service organizations looking to outsource/offshore
Outsourcing consultants evaluate and compare the offerings of vendors
Medical transcription vendors to assess their competitive environment
American medical transcription companies looking for Indian partners
Venture Capital companies looking for investment opportunities
Researchers looking for detailed information on medical transcription outsourcing
The report is based on secondary data as well as extensive interviews with key people at various medical transcription outsourcing companies in India.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=71846
_______________________________________________________________

The outsourcing industry is evolving rapidly; as new players, offshore destinations and a bewildering array of new services emerge. This is making it extremely difficult for senior executives at buyer organizations, outsourcing vendors, consultants and investors to stay abreast of the latest happenings in the sector.

The Outsourcing DealTracker is designed to provide comprehensive and up-to-date information on outsourcing to ensure that readers can stay abreast. The newsletter will consist of two parts:

● Mergers and acquisitions activity and venture capital and private equity funding
● Contracts

A comprehensive monthly resource tracking mergers and acquisition activity, venture capital and private equity funding, and contracts in the business process outsourcing and knowledge services outsourcing space. [Scope does not cover deals / contracts in the information technology industry].

The annual subscription, priced at $600, includes:
- twelve issues of the DealTracker which will be emailed as pdf attachment on the 7th of every month,
- 4 quarterly round-ups which will be emailed as pdf attachment on the 7th of January, April, July and October, and
- one annual round-up which will be emailed on the 7th of January.

For more information, kindly visit :
http://www.bharatbook.com/detail.asp?id=71856
_______________________________________________________________